Neurocrine Biosciences (NBIX) Earnings Date & Reports

Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

NBIX is expected to report earnings to rise 39.77% to 97 cents per share on August 05

Neurocrine Biosciences NBIX Stock Earnings Reports

Q2'25

Est.

$0.98

Q1'25

Missed

by $0.07

Q4'24

Beat

by $0.12

Q3'24

Beat

by $0.29

Q2'24

Beat

by $0.50

The last earnings report on May 05 showed earnings per share of 69 cents, missing the estimate of 76 cents. With 15.43K shares outstanding, the current market capitalization sits at 13.72B.

View a ticker or compare two or three

Compare

NBIX